Lv21
120 积分 2022-04-15 加入
A phase I study of fluzoparib tablet formulation, an oral PARP inhibitor: effect of food on the pharmacokinetics and metabolism after oral dosing in healthy Chinese volunteers
4小时前
已完结
LC-MS/MS Identification of Ozanimod Degradation Products and Development of a Green HPLC Method for Impurity Quantification
4小时前
求助中
Development and validation of a sensitive LC–MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients
8小时前
已完结
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
2个月前
已完结
Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment
3个月前
已关闭
Highly sensitive liquid chromatography–electrospray mass spectrometry (LC–MS) method for the determination of etoposide levels in human serum and plasma
4个月前
已完结
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid
5个月前
已完结
Determination of Oxaliplatin by a UHPLC-MS/MS Method: Application to Pharmacokinetics and Tongue Tissue Distribution Studies in Rats
7个月前
已完结
Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry
7个月前
已完结
Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry
8个月前
已完结
皖公网安备34019202002308
